Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05781737

Inflammatory Bowel Disease and Atherosclerosis Development

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
115 (actual)
Sponsor
I.M. Sechenov First Moscow State Medical University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis

Conditions

Timeline

Start date
2022-11-01
Primary completion
2024-01-30
Completion
2025-01-30
First posted
2023-03-23
Last updated
2024-10-04

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05781737. Inclusion in this directory is not an endorsement.

Inflammatory Bowel Disease and Atherosclerosis Development (NCT05781737) · Clinical Trials Directory